IGS firm wins patent lawsuit
BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems, has prevailed in its patent battle with Nomos. BrainLAB announced Feb. 9 that the U.S. Court of Appeals for the Federal Circuit in Washington, DC, has upheld a
BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems, has prevailed in its patent battle with Nomos. BrainLAB announced Feb. 9 that the U.S. Court of Appeals for the Federal Circuit in Washington, DC, has upheld a lower court ruling that BrainLAB's ExacTrac product does not infringe U.S. patent 5,411,026 for Nomos' BAT ultrasound-based target locating device. ExacTrac is BrainLAB's patient positioning system for the treatment of tumors with stereotactic radiotherapy/radiosurgery. The system's ultrasound localization allows a daily verification of the position of organs, such as the prostate or liver, which improves the precision of radiotherapy by allowing adjustments for shifts in organ position.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
